by Review

July 22, 2020

A new study led by Albert Einstein College of Medicine and Montefiore Health System confirms the findings of the large scale British trial of steroid use for COVID-19 patients and advances the research by answering several key questions: Which patients are most likely to benefit from steroid therapy? Could some of them be harmed? Can other formulations of steroids substitute for the agent studied in the British trial? The research was published today in the Journal of Hospital Medicine.

This post was originally published on this site

About the author 

Review

Leave a Reply

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Title Goes Here


Get this Free E-Book

Use this bottom section to nudge your visitors.